SCYNEXIS, Inc. (SCYX) - Stock Prices, Stock Peers & Analysis

Home
SCYX

Company Name	SCYNEXIS, Inc.
Symbol	SCYX
Currency	USD
Price	1.41
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	53,508,090
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.901 - 3.07
Industry	Drug Manufacturers—Specialty & Generic
Sector	Healthcare
CEO	Mr. David Gonzalez Angulo M.D.
Website	https://www.scynexis.com

An error occurred while fetching data.

About SCYNEXIS, Inc.

SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal